NCT03765437View on ClinicalTrials.gov

Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in Vietnam

PHASE3CompletedINTERVENTIONAL

Enrollment

230

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

March 17, 2019

Study Completion Date

March 17, 2019

Conditions

Influenza

Interventions

BIOLOGICAL

Quadrivalent Influenza Vaccine

Pharmaceutical form: Suspension for injection Route of administration: Intramuscular

Trial Locations (1)

84

Investigational Site Number 7040001, Việt Trì

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT03765437 - Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in Vietnam | Biotech Hunter | Biotech Hunter